Target
Complement factor D
Ligand
BDBM330256
Substrate
n/a
Meas. Tech.
Human Factor D Assay
IC50
<1000±n/a nM
Citation
 Wiles, JAHashimoto, AGadhachanda, VRPais, GWang, QChen, DWang, XAgarwal, ADeshpande, MPhadke, AS Phosphonate compounds for treatment of complement mediated disorders US Patent  US9663543 Publication Date 5/30/2017 
Target
Name:
Complement factor D
Synonyms:
Adipsin | C3 convertase activator | CFAD_HUMAN | CFD | DF | PFD | Properdin factor D
Type:
Protein
Mol. Mass.:
27039.19
Organism:
Homo sapiens (Human)
Description:
P00746
Residue:
253
Sequence:
MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA
  
Inhibitor
Name:
BDBM330256
Synonyms:
1-(2-((2S,4R)-2-(3-chloro- 2-fluorobenzylcarbamoyl)- 4-fluoropyrrolidin-1-yl)-2- oxoethyl)-3-(2,2,2- trifluoroacetyl)-1H-indol-6- ylphosphonic acid | US10301336, Comp No. 32 | US9663543, Compound 32
Type:
Small organic molecule
Emp. Form.:
C24H20ClF5N3O6P
Mol. Mass.:
607.851
SMILES:
OP(O)(=O)c1ccc2c(cn(CC(=O)N3C[C@H](F)C[C@H]3C(=O)NCc3cccc(Cl)c3F)c2c1)C(=O)C(F)(F)F |r|
Structure:
Search PDB for entries with ligand similarity: